Back to calendar
SELLAS Life Sciences Group, Inc. (SLS) Earnings
SLS reports earnings on Wednesday, November 18, 2026
earnings report
November 18, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.05
Actual EPS: $-0.05
EPS surprise: -11.11%
Company overview
Market Cap$2.0B
PriceUSD 9.68
EPS (TTM)-0.21
52-week high15.88
52-week low1.39
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees13